Carmaker Volvo cut its earnings expectations for 2025, citing complex market conditions and uncertainty around worldwide trade wars.
Related Posts
Eli Lilly to Buy Morphic Holding for $3.2 Billion
Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
European IPO Revival Still Lags Behind U.S.
Europe’s market for initial public offerings got off to a lively start in the fourth quarter, winding down a better year for new listings, though […]
XPeng Loss Narrows on Higher Sales
XPeng’s second-quarter net loss narrowed on stronger sales, higher revenue from its collaboration with Volkswagen and improved margins.